Shanghai Chuangshi Medical Technology (Group) Co., Ltd.

Form 483 issued September 13, 2024 · Qingpu, China

Inspection
Sep 9 – Sep 13, 2024
Investigator
Monica E. Murie
Observations
3
Pages
3
FEI number
3005023997

In short: On September 13, 2024, FDA issued a Form 483 with 3 observations to Shanghai Chuangshi Medical Technology (Group) Co., Ltd. in Qingpu, Shanghai (FEI 3005023997) after an inspection that ran Sep 9 – Sep 13, 2024. The investigator was Monica E. Murie. Most observations concern laboratory controls and materials.

At a glance

Laboratory controls and materials account for 2 of 3 observations.

Laboratory controls1
Materials1
Production1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    The written stability program for drug products does not include reliable, meaningful…

  2. 02

    The identity of each component of a drug product is not verified by conducting at least…

  3. 03

    Procedures designed to prevent objectionable microorganisms in drug products not required to be sterile are not…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Shanghai Chuangshi Medical Technology (Group) Co., Ltd.?

FDA listed 3 observations on this Form 483, mostly about laboratory controls, materials and production. The opening words of each observation are shown on this page.

Who inspected Shanghai Chuangshi Medical Technology (Group) Co., Ltd.?

Monica E. Murie is named on this Form 483, for the inspection of Sep 9 – Sep 13, 2024. Each investigator has a profile showing what they cite most.

When was Shanghai Chuangshi Medical Technology (Group) Co., Ltd. inspected by FDA?

The inspection ran Sep 9 – Sep 13, 2024, and the Form 483 is dated September 13, 2024.

How do I get the full Form 483 for Shanghai Chuangshi Medical Technology (Group) Co., Ltd.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free